Boosted individuals were more likely to get nasal congestion and/or a sore throat and less likely to experience body and muscle aches.

Getting a COVID-19 booster shot and its timing may affect the frequency and type of symptoms in breakthrough SARS-CoV-2 infections.

A recently published study in Vaccines found that boosted individuals were significantly more likely to get nasal congestion and/or a sore throat but considerably less likely to experience body and muscle aches, compared with those who were vaccinated but had not received a booster dose during the Omicron surge.
Additionally, the frequency of fever and cough symptoms was directly associated with increased time between vaccine doses. With each booster vaccination, the likelihood of having a fever and cough increased by 4.4 percent and 4.8 percent, respectively.

Posted in

Iron Will

Leave a Comment

You must be logged in to post a comment.